WallStSmart

Certara Inc (CERT)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 589% more annual revenue ($2.89B vs $418.84M). CERT leads profitability with a -0.4% profit margin vs -7.3%. MMED earns a higher WallStSmart Score of 37/100 (F).

CERT

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 6.3
Piotroski: 4/9Altman Z: 1.56

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CERT1 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

MMED0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CERT4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
3.3%4/10

3.3% revenue growth

Altman Z-ScoreHealth
1.564/10

Distress zone — elevated risk

Market CapQuality
$995.46M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.1%3/10

Operating margin of 2.1%

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CERT

The strongest argument for CERT centers on Price/Book.

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : CERT

The primary concerns for CERT are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Key Dynamics to Monitor

MMED is growing revenue faster at 13.1% — sustainability is the question.

CERT generates stronger free cash flow (28M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 34/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Certara Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?